Volume 16, Issue 2, February 2019 - First Report Managed Care
02/22/2019
In the summer of 2018, First Report Managed Care reported on the Trump Administration’s drug price blueprint and checked back in during the fall to track progress. Now in the new year, First Report Managed Care’s panel of experts parsed...
In the summer of 2018, First Report Managed Care reported on the Trump Administration’s drug price blueprint and checked back in during the fall to track progress. Now in the new year, First Report Managed Care’s panel of experts parsed...
In the summer of 2018, First...
02/22/2019
First Report Managed Care
Department
Conference Insider
02/22/2019
According to a study presented at the AHA/ASA International Stroke Conference 2019, “The greater the volume of blood removed from the brain via minimally invasive surgery after a hemorrhagic stroke the greater the odds of better functional...
According to a study presented at the AHA/ASA International Stroke Conference 2019, “The greater the volume of blood removed from the brain via minimally invasive surgery after a hemorrhagic stroke the greater the odds of better functional...
According to a study presented...
02/22/2019
First Report Managed Care
Conference Insider
02/22/2019
In-home telerehabilitation was proven to be just as effective as clinic-based therapy at restoring arm function after a stroke according to late-breaking science presented at the AHA/ASA International Stroke Conference 2019 in Honolulu, HI.
In-home telerehabilitation was proven to be just as effective as clinic-based therapy at restoring arm function after a stroke according to late-breaking science presented at the AHA/ASA International Stroke Conference 2019 in Honolulu, HI.
In-home telerehabilitation was...
02/22/2019
First Report Managed Care
Conference Insider
02/22/2019
A study presented at the AHA/ASA International Stroke Conference 2019 explained that intravenous (IV) insulin did not improve stroke outcomes in comparison to the standard blood sugar control using shots.
A study presented at the AHA/ASA International Stroke Conference 2019 explained that intravenous (IV) insulin did not improve stroke outcomes in comparison to the standard blood sugar control using shots.
A study presented at the AHA/ASA...
02/22/2019
First Report Managed Care
Conference Insider
02/22/2019
Researchers presented successful results on “Integrating the COMprehensive Post-Acute Stroke Services (COMPASS) Model into Routine Care” at the AHA/ASA International Stroke Conference 2019 in Honolulu, HI, this month.
Researchers presented successful results on “Integrating the COMprehensive Post-Acute Stroke Services (COMPASS) Model into Routine Care” at the AHA/ASA International Stroke Conference 2019 in Honolulu, HI, this month.
Researchers presented successful...
02/22/2019
First Report Managed Care
Conference Insider
02/22/2019
According to a study presented at the AHA/ASA International Stroke Conference 2019, hospitals utilizing the Target: Stroke Phase II strategies were able to decrease door-to-needle (DTN) time from 66 minutes to 51 minutes.
According to a study presented at the AHA/ASA International Stroke Conference 2019, hospitals utilizing the Target: Stroke Phase II strategies were able to decrease door-to-needle (DTN) time from 66 minutes to 51 minutes.
According to a study presented...
02/22/2019
First Report Managed Care
